Order Article Reprints

Nakamoto K, Watanabe M, Saito M, Kasuga K, Miyaoka C, Yoshida Y, Kobayashi F, Nunokawa H, Aso J, Nakamoto Y, et al. Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study. Journal of Clinical Medicine. 2024; 13(19):6022. https://doi.org/10.3390/jcm13196022

Nakamoto, Keitaro, Masato Watanabe, Masaoki Saito, Keisuke Kasuga, Chika Miyaoka, Yuki Yoshida, Fumi Kobayashi, Hiroki Nunokawa, Jumpei Aso, Yasuo Nakamoto, and et al. 2024. "Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study" Journal of Clinical Medicine 13, no. 19: 6022. https://doi.org/10.3390/jcm13196022

Nakamoto, K., Watanabe, M., Saito, M., Kasuga, K., Miyaoka, C., Yoshida, Y., Kobayashi, F., Nunokawa, H., Aso, J., Nakamoto, Y., Ishida, M., Sada, M., Honda, K., Takata, S., Saraya, T., Shimoda, M., Tanaka, Y., Saotome, M., Ohta, K., & Ishii, H. (2024). Serum Derivatives–Reactive Oxygen Metabolite Levels as a Marker of Clinical Conditions in Patients with Bronchial Asthma, COPD, or Asthma–COPD Overlap: A Prospective Study. Journal of Clinical Medicine, 13(19), 6022. https://doi.org/10.3390/jcm13196022